Jonušaitė, I., et al. “The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of Ofatumumab”. Neurologijos Seminarai, vol. 27, no. 3 (97), Mar. 2024, pp. 127-35, https://doi.org/10.29014/NS.2023.27.97.1.